Related by context. Frequent words. (Click for all words.) 58 XL# [003] 57 LX# [003] 56 RP# [002] 56 DG# [001] 54 NP# [002] 53 kinase inhibitor 53 NGX# 52 MB# [004] 52 sapacitabine 52 #ME# 52 MGCD# [001] 52 TRIOLEX 52 Preclinical studies 52 AV# [003] 51 BAY #-# 51 GRN#L 51 PRX# 51 antitumor activity 51 CYT# 50 MP# [002] 50 CA4P 50 HGS ETR1 50 ADL# 50 AZD# 49 ISIS # 49 ENMD 49 AR# [001] 49 CX# [004] 49 BiTE antibody 49 ATryn R 49 Locteron 49 HE# [002] 49 daclizumab 49 humanized monoclonal antibody 49 LX# [002] 49 TM# [001] 48 MT# [002] 48 Phase Ib 48 cutaneous T cell 48 Perifosine 48 Phase 2b 48 monotherapy 48 CB# [002] 48 pralatrexate 48 Phase 1b clinical 48 PLX# 48 potent inhibitor 48 lupus nephritis 48 phase IIb 48 selective estrogen receptor 48 MBX 48 vandetanib 47 elesclomol 47 RG# [001] 47 Sorafenib 47 dose limiting toxicities 47 Phase 2b clinical 47 EX# [002] 47 Phase IIb clinical 47 Rituximab 47 Phase 2a 47 SL# [004] 47 HspE7 47 pharmacokinetic profile 47 investigational compound 47 tivozanib 47 TORISEL 47 pharmacodynamic 47 CX# [002] 47 antiviral activity 46 Zerenex 46 Phase 2a trial 46 VEGF Trap 46 APD# 46 ofatumumab 46 eltrombopag 46 AACR NCI EORTC 46 AP# [003] 46 PRX # 46 ZYBRESTAT 46 receptor agonist 46 Phase 2b study 46 AX# [001] 46 IND enabling 46 Phase 2b trial 46 RDEA# 46 Phase IIa trial 46 Phase IIb 46 MGCD# [002] 46 IMGN# 46 eculizumab 46 TREANDA 46 PEG Interferon lambda 46 investigational oral 46 ALN RSV# 46 metastatic renal cell carcinoma 46 TLR7 46 ANA# 46 CoFactor 46 Satraplatin 46 Alpharadin